Clinical outcomes of upgrade to versus de novo cardiac

PDF) Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions The REALITY Trial: A Randomized Controlled Trial

Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?

Comparative Analysis of Procedural Outcomes and Complications Between De Novo and Upgraded Cardiac Resynchronization Therapy

PDF) Clinical outcomes after upgrade to resynchronization therapy: a propensity-score matched comparative analysis

Heart failure: an update from the last years and a look at the near future - Riccardi - 2022 - ESC Heart Failure - Wiley Online Library

The importance of copy number variation in congenital heart disease

Heart Failure in Type 2 Diabetes Mellitus

De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry - ScienceDirect

The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients - Oh - 2022 - ESC Heart Failure - Wiley Online Library